changes that result in iPSCs with distinct cell polarity, boundaries and cell-cell interactions. The cells start expressing E-cadherin, a marker for epithelial cells 5 , which is also highly expressed in human embryonic stem cells (hESCs). We reasoned that factors that promote the mesenchymal to epithelial transition, such as TGFβ pathway antagonists, would have a direct impact on the reprogramming process. In addition, MEK-ERK pathway inhibition previously had been shown to be important in various reprogramming steps 6, 7 . Furthermore, factors promoting cell survival could also be beneficial in improving reprogramming efficiency. Consequently, we focused on small molecules that can regulate these three processes and pathways, as the use of small molecules has many advantages 4, 7, 8 in studying biological processes and they are a safer choice than genetic manipulation. Here we describe a simple chemical platform that substantially enhances generation of fully reprogrammed human iPSCs from fibroblasts through a much faster and more efficient process.
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We tested known inhibitors of TGFβ receptor and MEK on 1 × 10 4 human primary fibroblasts (CRL2097 or BJ) that we retrovirally transduced with cDNAs encoding the 4TFs, for their effect on reprogramming (Fig. 1a) . On day 7 after infection, we added the compounds, individually or in combinations, and examined the cultures for iPSCs over the next 1-3 weeks.
On day 7 after treatment (day 14) we observed the strongest effect in the cultures treated with a combination of ALK5 inhibitor SB431542 (2 µM) and MEK inhibitor PD0325901 (0.5 µM), which resulted in ~45 large alkaline phosphatase (ALP)-positive colonies (Fig. 1b) with characteristic hESC-like morphology, of which over 24 colonies were TRA-1-81 + (Fig. 1c) , and six to ten colonies stained positive for SSEA4 in addition to NANOG, a mature pluripotency factor that was not ectopically introduced ( Fig. 1d,e) . Moreover, the treated cultures had high expression of endogenous mRNA for the pluripotency genes (Fig. 1f) . In contrast, we did not observe any NANOG + colonies in the untreated control cultures or in cultures that we treated with PD0325901 alone (Fig. 1e and Supplementary Fig. 1a) . However, in cultures treated with only SB431542, we observed 1-2 ALP + hESC-like colonies (Supplementary Fig. 1a) . Notably, the combined effect of both inhibitors (Supplementary Fig. 1b,c) , as well as the individual effect of SB431542 (data not shown) was dose-dependent.
When we maintained the SB431542 plus PD0325901-treated cultures for 30 d without splitting, we obtained about 135 iPSC colonies per well (Fig. 1g) , a >100-fold improvement in efficiency over the conventional method. Consistent with previous reports 1 Recent advances in generating human induced pluripotent stem cells (iPSCs) [1] [2] [3] have raised hopes for the utility of these cells in biomedical research and clinical applications 4 . However, iPSC generation is still a very slow (~4 weeks) and inefficient (≤0.01% 1,2 ) process that results in a heterogeneous population of cells. Identifying fully reprogrammed iPSCs from such a mixture is tedious and requires expertise in human pluripotent cell culture.
Although recently developed methods (for example, protein transduction) 3 for iPSC generation mitigate the risk of genomic insertions of exogenous reprogramming factors, the low efficiency and slow kinetics of reprogramming continue to present a problem for ultimate applications of human iPSCs. For example, genetic or epigenetic abnormalities could be enriched during the reprogramming process, where tumor suppressors may be inhibited and oncogenic pathways may be activated. Though recent studies have reported an improved efficiency of reprogramming by genetic manipulations 4 in addition to using the original four factors, they typically make the process even more complex and increase the risk of genetic alterations and tumorigenicity. Thus there is still a tremendous need for a safer, easier and more efficient procedure for human iPSC generation, which would also facilitate identifying and characterizing fundamental mechanisms of reprogramming.
During reprogramming mediated by four factors (4TF) encoded by OCT4 (POU5F1), SOX2, KLF4 and c-MYC (MYC), mesenchymal-type fibroblasts undergo dramatic morphological colonies after 30 d of culture. These granulate structures have been suggested to be partially reprogrammed colonies 1 . We also observed granulate colonies in SB431542-treated cultures, which outnumbered by several fold the few hESC-like colonies. Notably, the number of granulate colonies was dramatically lower after the combined SB431542 and PD0325901 treatment, which resulted in a concomitant increase in the number of hESC-like colonies. This suggested that a combined inhibition of ALK5 and MEK may guide partially reprogrammed colonies to a fully reprogrammed state, thereby improving the overall reprogramming process. Moreover, that we observed improved induction of iPSCs as early as 7 d after treatment, suggests that treatment with these small molecules not only improves the efficiency of the reprogramming process but may also accelerate its kinetics (Fig. 1a) , although additional experiments are required to determine whether the reprogrammed cells at this stage indeed become fully independent of exogenous reprogramming factors earlier than in untreated cultures.
Although we could pick and expand the iPSC colonies, as in hESC cultures, splitting the cultures by trypsinization resulted in poor survival. From a recent screen performed in our laboratory using an in-house collection of compounds, we identified a small molecule, thiazovivin (Supplementary Fig. 2 ), which dramatically improves the survival of hESCs upon trypsinization (X.Y. and S.D.; unpublished data). Addition of thiazovivin to our cocktail of SB431542 and PD0325901 also improved the survival of iPSCs after splitting by trypsinization (Fig. 2a) and meant that we could obtain many reprogrammed colonies. From 10,000 cells that we originally seeded, a single 1:4 splitting on day 14 resulted in ~1,000 hESC-like colonies on day 30 (Fig. 2b) , and two rounds of splitting (on day 14 and on day 21 (1:10)) resulted in ~11,000 hESC-like colonies (Fig. 2b,c) on day 30. These colonies had high levels of endogenous mRNA (Fig. 2d) and protein expression (Fig. 2c,e) of pluripotency markers, whereas the expression of the four transgenes could hardly be detected (Fig. 2d) . In contrast, we did not obtain any iPSC colonies from untreated or two compound-treated samples that we trypsinized (Supplementary Table 1) .
To examine whether the enhancement in reprogramming observed in thiazovivin-treated cultures was solely due to survival of colonies after splitting or whether it also augmented the reprogramming effect of combined SB431542 and PD0325901 treatment, we tested the three-compound cocktail, without cell splitting, on cells transduced with cDNAs encoding the 4TFs. In these cultures, by day 14, we observed ~25 large colonies that all expressed NANOG (Fig. 1e) . By day 30 we observed ~205 very large NANOG + colonies (Fig. 1g) , that were also TRA-1-81 + and SSEA4 + (data not shown), which translates to a more than 200-fold improvement in reprogramming efficiency over the no-compound treatment and a twofold increase over the two-compound treatment.
Two-compound treatment also resulted in more ALP + colonies compared to untreated controls when the reprogramming factors were introduced using a lentiviral, rather than a retroviral system (Supplementary Fig. 3a) . Furthermore, the three-compound cocktail did not appear to influence reprogramming factor expression from retroviral vectors (Supplementary Fig. 3b-f) . The iPSC colonies generated using the three-compound cocktail could be readily and stably expanded for long term under conventional hESC culture conditions (over 20 passages), and they closely resembled hESCs in terms of morphology, typical pluripotency marker expression and differentiation potentials. They exhibited a normal karyotype (Supplementary Fig. 4 ) and could be differentiated into derivatives of all three germ layers, both in vitro (Fig. 3a,b ) and in vivo (Fig. 3c) . These results also suggest that there was no short-term adverse effect associated with the use of the much more convenient trypsinization procedure, although we cannot entirely rule out longterm effects.
The finding that TGFβ and MEK-ERK pathway inhibition improved fibroblast reprogramming suggests critical roles for these two signaling pathways and mesenchymal to epithelial transition mechanisms in the process. Consistently, the addition of TGFβ has an inhibitory effect on fourfactor-mediated reprogramming of fibroblasts (data not shown). TGFβ and its family members have important roles in self-renewal and differentiation of embryonic stem cells 9 . Moreover, TGFβ is a prototypical cytokine for induction of epithelial-mesenchymal transition and maintenance of the mesenchymal state 10 . A major end point of this signaling, in this context, is downregulation of E-cadherin 11 . E-cadherin has been shown to be important for the maintenance of pluripotency of embryonic stem cells and has been recently suggested to be a regulator of NANOG expression 12 . Therefore inhibition of TGFβ signaling, which results in de-repression of epithelial fate, could benefit the reprogramming process in multiple ways. ERK signaling also promotes epithelial-mesenchymal transition 11 and is downstream of TGFβ in the process 12 . We had previously shown that the effect of reversine, a small molecule that can reprogram myoblasts to a multipotent state, is mediated in part through inhibition of MEK-ERK 6 . This may explain the effect observed in reprogramming when it was combined with TGFβ inhibition. Concurrent with this study, two other studies reported an improvement in reprogramming efficiency in human cells, either by epigenetic manipulation 13 or by reprogramming keratinocytes 14 . However, the chemical platform described here is unique, in that it modulates upstream signaling pathways and could radically improve reprogramming on a general cell type, like fibroblasts. The chemical conditions described here could provide a basic platform on which a non-viral and non-DNAbased 15 , more efficient and safer reprogramming process could be developed, which could yield an unlimited supply of safer human iPSCs for various applications. methods Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturemethods/. 
